2,864 matches for your search in the start-up spotlight
rss
Almost half of all men and one third of all women come down with cancer once in their lifetime. But: almost all kinds of cancer are remediable if diagnosed early. In the case of cervical cancer, diagnosed pre-stages are almost 100% curable. oncgnostics GmbH, a spin-off of the university hospital ...
Cysal GmbH uses an internationally patented, biotechnological process to produce arginineaspartate and lysine-aspartate dipeptides on an industrial scale. The biotechnology company uses these dipeptides, a combination of two amino acids, as the base material for the ...
BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company's award-winning TRIC ...
A new star is born, a new light in the sky of bioanalytics: Accelerō® Bioanalytics. Inspired by expert knowledge. Old hands at work. We are committed to become a preferred partner in bioanalytical services for the nucleic acids biotechnology and pharmaceutical industry. Accelerō® Bioanalytics ...
Spindiag is a spin-off of Hahn-Schickard, one of the world's leading research institutions for microsystems technology. Based on its patented microfluidic platform "LabDisk", Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable ...
The object of the company is the development and marketing of the TolerogenixX process in various severe and most severe indications. It is a cell therapy procedure, innovation and unique selling point is the specific suppression of the immune reaction in the sense of an individualized ...
We are a company focused on the research, development and manufacturing of innovative diagnostic tests to determine risk factors of dementia-related diseases. We have set ourselves the goal of being able to diagnose the various forms of dementia earlier and more reliably through the innovative ...
